Compare PRIM & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRIM | ALKS |
|---|---|---|
| Founded | 1960 | 1987 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Water Sewer Pipeline Comm & Power Line Construction | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.8B | 5.5B |
| IPO Year | N/A | 1991 |
| Metric | PRIM | ALKS |
|---|---|---|
| Price | $147.26 | $34.00 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 15 | 13 |
| Target Price | ★ $143.73 | $42.85 |
| AVG Volume (30 Days) | 721.3K | ★ 2.3M |
| Earning Date | 02-23-2026 | 02-13-2026 |
| Dividend Yield | ★ 0.22% | N/A |
| EPS Growth | ★ 66.70 | 2.44 |
| EPS | ★ 5.05 | 2.02 |
| Revenue | ★ $7,458,609,000.00 | $1,521,338,000.00 |
| Revenue This Year | $20.53 | N/A |
| Revenue Next Year | $6.66 | $22.83 |
| P/E Ratio | $29.35 | ★ $16.84 |
| Revenue Growth | ★ 21.45 | 1.08 |
| 52 Week Low | $49.10 | $25.17 |
| 52 Week High | $155.19 | $36.45 |
| Indicator | PRIM | ALKS |
|---|---|---|
| Relative Strength Index (RSI) | 58.66 | 67.09 |
| Support Level | $146.34 | $32.49 |
| Resistance Level | $153.51 | $35.29 |
| Average True Range (ATR) | 5.75 | 1.18 |
| MACD | 0.43 | 0.29 |
| Stochastic Oscillator | 71.00 | 77.75 |
Primoris Services Corp is a provider of infrastructure services operating mainly in the United States and Canada. It provides a wide range of construction services, maintenance, replacement, fabrication and engineering services to a diversified base of customers. The reportable segments are the Utilities segment and the Energy segment. The Utilities segment operates in a range of services, including the installation and maintenance of new and existing natural gas and electric utility distribution and transmission systems, and communication systems. The Energy segment operates in a range of services that include engineering, procurement, and construction, retrofits, highway and bridge construction, demolition, site work, outages, pipeline construction and maintenance, and others.
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.